Search Within

Clinical Pharmacy Specialists

Formats
  1. Journal Article (136)
  2. Meeting Abstract (130)
  3. Research Letter (10)
  4. Guidelines (6)
  5. Review (6)
  6. Book Section (5)
  7. Editorial (2)
  8. Miscellaneous (2)
Groups
  1. Department of Medicine (220)
  2. Center for Hematologic Malignancies (143)
  3. Hematologic Malignancies, Division of (139)
  4. Survivorship Research (105)
  5. Hematology-Oncology Fellows (95)
  6. Bone Marrow Transplant (88)

More Groups

People
  1. Sergio Giralt (64)
  2. Andrew Lin (52)
  3. Gunjan Shah (46)
  4. Dazhi Liu (45)
  5. Michael Scordo (41)
  6. Susan Seo (35)

More People

Years
  1. 2025 (17)
  2. 2024 (49)
  3. 2023 (28)
  4. 2022 (33)
  5. 2021 (13)
  6. 2020 (14)

More Years

Publications
  1. Blood (42)
  2. Biology of Blood and Marrow Transplantation (27)
  3. Journal of Clinical Oncology (21)
  4. Blood Advances (13)
  5. Pediatric Blood and Cancer (13)
  6. Clinical Lymphoma, Myeloma and Leukemia (11)

More Publications

Publishers
  1. Elsevier Inc. (61)
  2. American Society of Hematology (55)
  3. American Society of Clinical Oncology (25)
  4. Oxford University Press (17)
  5. Springer (13)
  6. Wiley Periodicals, Inc (13)

More Publishers

Results (297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia
    Meeting Abstract

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Blood (2019)

    Fulltext@MSK | Save
  • A retrospective analysis of the effect of isavuconazole on immunosuppressant serum blood levels and intravenous to oral dose adjustments
    Meeting Abstract

    Proli, A. J.; Bhatt, V.; Lin, A.; Lau, C.; Griffin, M.; DeRespiris, L.; Maples, K. T.; Figgins, B.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Meeting Abstract

    Maples, K. T.; Maloy, M. A.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity analysis of propylene glycol-free melphalan (Evomela®) compared to propylene glycol-based melphalan hydrochloride in autologous hematopoietic cell transplantation for multiple myeloma
    Meeting Abstract

    DeRespiris, L.; Bhatt, V.; Lin, A.; Maloy, M. A.; Chung, D. J.; Landau, H.; Scordo, M.; Giralt, S. A.; Shah, G. L.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study
    Meeting Abstract

    Reiss, S.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience
    Journal Article

    Lin, A.; Maloy, M.; Su, Y.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A.; Barker, J.; Shaffer, B.; more...
    Transplant Infectious Disease (2019)

    Fulltext@MSK | Save
  • Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl
    Journal Article

    Moryl, N.; Bokhari, A.; Griffo, Y.; Hadler, R.; Koranteng, L.; Filkins, A.; Zheng, T.; Horn, S. D.; Inturrisi, C. E.
    Cancer Medicine (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save